Experience

Regeneron Pharmaceuticals Inc v. Kymab Ltd.*

Regeneron Pharmaceuticals Inc.

Kymab Ltd.

Represented Regeneron against Kymab on patents covering a transgenic mouse platform for antibody discovery in its appeal.

Regeneron Pharmaceuticals Inc. v. Kymab Ltd., [2020] UKSC 27, Appeal number: UKSC 2018/0131, Supreme Court of the United Kingdom

Related Professionals

Jin Ooi
Partner
London
+44 20 7864 2821
Email

Related Practices

Diligence, Licensing, and Opinions

Licensing, Pooling, and Other Transactions

Related Industries

Life Sciences

Medical Device and Diagnostics

*Matter handled prior to joining Finnegan.

Related Experiences

Lupin Pharmaceuticals, Inc. v. Pozen Inc.

Horizon Pharma USA, Inc.; Pozen Inc.

InnoPharma Licensing, Inc.; Lupin Ltd.; and Metrics, Inc. v. Senju Pharmaceuticals Co.

Bausch Health Companies

Valeant Pharmaceuticals International, Inc. v. Mylan Pharmaceuticals Inc.

Valeant Pharmaceuticals International, Inc.

Elan Pharmaceuticals, Inc. v. Ivax Pharmaceuticals, Inc.

Elan Pharmaceuticals, Inc.

Valeant Pharmaceuticals Int’l, Inc. v. Mylan Pharmaceuticals, Inc. 

Valeant; Salix; Progenics

Rocket Pharmaceuticals, Inc. v. Lexeo Therapeutics, Inc., et al.

Rocket Pharmaceuticals, Inc.

Mylan Pharmaceuticals Inc. v. Senju Pharmaceutical Co., Ltd.

Senju Pharmaceutical Co., Ltd.; Bausch & Lomb Incorporated

Housey Pharmaceuticals, Inc. v. Otsuka Pharmaceutical Co. Ltd.

Otsuka Pharmaceutical Co. Ltd.

GlaxoSmithKline v. Synthon Pharmaceuticals, Inc. 

GlaxoSmithKline

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.